JPMorgan Chase Holds Q2 2026 Investor Earnings Presentation, Furnishes Slides Under Regulation FD

JPMorgan Chase Q2 2026 Earnings Presentation: What the Disclosure Covers

On July 14, 2026, JPMorgan Chase & Co. announced that it had held an investor presentation to review its second quarter 2026 earnings results. The announcement confirmed that earnings presentation slides were furnished as Exhibit 99 alongside the current report. These slides were simultaneously posted on the firm's corporate website for public access in connection with the presentation event.

The disclosure was made pursuant to Item 7.01 of the current report requirements, which governs Regulation FD disclosures. Under this framework, the information contained in the slides and the report itself is explicitly noted as not being "filed" in the traditional sense, meaning it does not carry the same legal liability treatment as formally filed documents under Section 18 of the Securities Exchange Act of 1934. This is a standard mechanism used by large public companies when voluntarily sharing investor materials broadly and simultaneously.

Regulation FD Compliance and the Legal Status of Furnished Exhibits

The filing makes clear that the earnings slides furnished as Exhibit 99 are subject to specific legal limitations. The information contained in the exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is therefore not subject to the liabilities arising under that section. This distinction is important for investors and analysts who rely on such materials, as it affects the legal framework within which the information was provided.

Additionally, the filing states that the information in Exhibit 99 shall not be deemed incorporated by reference into any of JPMorgan Chase's filings under the Securities Act of 1933. This language is standard for Regulation FD filings and serves to limit the scope of the furnished materials. Investors seeking to rely on specific financial data from the presentation should consult the full slides directly through the firm's website or through the SEC's public filing system at www.sec.gov.

Forward-Looking Statements and Risk Factors Referenced in the Report

The disclosure includes a forward-looking statements notice, advising that the current report and its accompanying exhibit contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, the filing notes, are based on the beliefs and expectations of JPMorgan Chase's management and speak only as of the date on which they were made, July 14, 2026.

The filing further cautions that actual results may differ materially from those described in any forward-looking statements. It directs investors to JPMorgan Chase's Annual Report for the year ended December 31, 2025, and the Quarterly Report for the quarter ended March 31, 2026, both filed with the SEC, as sources identifying factors that could cause actual results to differ. JPMorgan Chase also noted in the filing that it does not undertake to update any forward-looking statements made in connection with this disclosure.

Registered Securities Covered Under This Corporate Disclosure

The disclosure lists a broad range of securities registered by JPMorgan Chase & Co. under Section 12(b) of the Securities Exchange Act, many of which trade on the New York Stock Exchange. These include JPMorgan Chase's common stock, trading under the symbol JPM on the NYSE, as well as several series of depositary shares representing fractional interests in non-cumulative preferred stock. The preferred stock series listed include Series DD at 5.75%, Series EE at 6.00%, Series GG at 4.75%, Series JJ at 4.55%, Series LL at 4.625%, and Series MM at 4.20%, each representing a one-four hundredth interest in a share of the respective preferred stock.

Beyond equity-linked instruments, the filing also identifies debt and structured products issued by JPMorgan Chase Financial Company LLC and guaranteed by JPMorgan Chase & Co. These include Callable Fixed Rate Notes due June 10, 2032 (trading as JPM/32 on the NYSE), Alerian MLP Index ETNs due January 28, 2044 (trading as AMJB on NYSE Arca), and Inverse VIX Short-Term Futures ETNs due March 22, 2045 (trading as VYLD on NYSE Arca). The VYLD instrument, a guarantee of inverse VIX short-term futures exchange-traded notes, represents a structured product linked to volatility futures market dynamics.

VYLD: JPMorgan Chase's Inverse VIX Short-Term Futures ETNs Explained

The VYLD ticker, listed on NYSE Arca, represents JPMorgan Chase Financial Company LLC's Inverse VIX Short-Term Futures ETNs, which are due to mature on March 22, 2045. These exchange-traded notes are guaranteed by JPMorgan Chase & Co. as the parent entity, and their inclusion among registered securities underscores the firm's broad structured products business. Inverse VIX ETNs are designed to provide exposure that moves in the opposite direction to short-term VIX futures indices, making them instruments with specific risk characteristics tied to equity market volatility conditions.

As a registered security covered by this corporate update, VYLD holders are among those who receive the benefit of JPMorgan Chase's parent-level guarantee. The filing does not provide specific details about the performance, net asset value, or trading information of VYLD in connection with this earnings presentation disclosure. Investors holding or monitoring VYLD as a structured product should be aware of its 2045 maturity date and its inverse volatility exposure profile as disclosed in the underlying product documentation.

JPMorgan Chase's Corporate Structure and Firmwide Operations

JPMorgan Chase & Co. is incorporated in Delaware and maintains its principal executive offices at 270 Park Avenue, New York, New York 10017. The firm operates as one of the largest diversified financial services companies in the United States, with operations spanning consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. Its broad range of registered securities — from common equity to preferred depositary shares to guaranteed structured notes — reflects the diversity and scale of its capital markets activities.

The Firmwide Controller who signed the current report on behalf of JPMorgan Chase & Co. is Elena Korablina, identified as Managing Director and Firmwide Controller, serving as the Principal Accounting Officer. Her signature on behalf of the registrant confirms that the disclosure meets the requirements of the Securities Exchange Act of 1934 as required for current reports of this nature.

Exhibit Structure: Earnings Slides and XBRL Data Filed Alongside the Report

The filing identifies three exhibits submitted or furnished alongside the current report. Exhibit 99 contains the JPMorgan Chase & Co. Earnings Presentation Slides covering Financial Results for the second quarter of 2026, which were the primary materials distributed during the July 14, 2026 investor presentation. These slides represent the substantive investor-facing content associated with the quarterly earnings review event.

Exhibit 101 was submitted pursuant to Rule 406T of Regulation S-T and contains the cover page formatted in Inline XBRL, the eXtensible Business Reporting Language standard used for structured financial data reporting. Exhibit 104 is described as the Cover Page Interactive Data File, which is embedded within the Inline XBRL document included in Exhibit 101. These technical exhibits are standard components of modern SEC-compliant current report submissions and support machine-readable data access for regulators and the public.

Alerian MLP Index ETNs and Callable Fixed Rate Notes Also Covered

In addition to the VYLD Inverse VIX ETNs, the disclosure also covers two other structured instruments issued by JPMorgan Chase Financial Company LLC and guaranteed by the parent. The Alerian MLP Index ETNs, trading as AMJB on NYSE Arca, are due January 28, 2044, and provide exposure linked to the Alerian MLP Index, which tracks master limited partnerships primarily in the energy infrastructure sector. These ETNs represent another dimension of JPMorgan Chase's structured products guarantee obligations.

The Callable Fixed Rate Notes due June 10, 2032, trading as JPM/32 on the NYSE, round out the structured debt instruments covered in this disclosure. These callable notes carry a fixed rate and are subject to early redemption at JPMorgan Chase Financial Company LLC's option under terms set out in the underlying instrument documentation. The filing does not elaborate on any changes, events, or performance information specific to either the AMJB or JPM/32 instruments in connection with this Q2 2026 earnings presentation disclosure.

What the Filing Does and Does Not Disclose About Q2 2026 Results

The current report itself does not contain specific financial figures, revenue data, net income figures, capital ratios, or segment-level results for the second quarter of 2026. The filing text is limited to confirming that the earnings presentation took place on July 14, 2026, and that the slides have been furnished as an exhibit. All detailed financial metrics, management commentary, and forward-looking guidance, if any, would be contained within the Exhibit 99 earnings presentation slides rather than within the body of this report.

Investors and analysts seeking specific financial metrics disclosed by JPMorgan Chase for Q2 2026 should refer directly to the earnings presentation slides as posted on the firm's investor relations website or filed with the SEC. The company did not disclose specific revenue, net income, or capital figures within the text of this filing. The immediate share price impact was not clear from available public information at the time of the filing.